Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it was found that the antipyretic effect of paracetamol is due to the inhibition of COX in the brain (84).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [84]
In the citing paper
“These novel findings explain the mechanism of action of paracetamol and may provide an explanation of the observation that paracetamol inhibits prostaglandin production in the brain (84).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [84]
In the citing paper
“Historically, Vane and Flower demonstrated that paracetamol reduced brain PGE2 with a preferred action in the CNS than in the periphery.8”
In the citing paper
“Flower and Vane (1972) who demonstrated potent inhibition of brain prostaglandin E 2 (PGE 2 ) synthesis (IC 50 = 12.5 µg/ml) compared to PGE 2 in the spleen (IC 50 = 100 µg/ml) indicating 8x more potent inhibition of PGE 2 synthesis in the brain than spleen, whereas several NSAIDs showed equipotent inhibition of brain and spleen PGE 2 synthesis [16].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [16]
In the citing paper
“However, the authors report on a conversion rate of plasma paracetamol to AM404 of only 0.0013%, which would result in low concentrations expected to have negligible pharmacological activities.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [16]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Self-citationThe Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationThe Pharmacological Basis of Therapeutics.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-149_1 · Cited by 881
A SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
VANE, J. R. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00146.x · Cited by 772
Self-citationProstaglandins released by the Spleen
Gilmore, N. J., Vane, J. R., & Wyllie, J. H. (1968) · Nature · doi:10.1038/2181135a0 · Cited by 548
Self-citationProstaglandins and related factors: XIX. Thin-layer chromatography of prostaglandins
Gréen, K., & Samuelsson, B. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40270-6 · Cited by 476
Effects of Anti-inflammatory Drugs on Prostaglandin Biosynthesis
FLOWER, R., GRYGLEWSKI, R., HERBACZŃSKA-CEDRO, K., & VANE, J. R. (1972) · Nature New Biology · doi:10.1038/newbio238104a0 · Cited by 475
Self-citationStimulation and Blockade of Prostaglandin Biosynthesis
Smith, W. L., & Lands, W. E. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34171-7 · Cited by 281
Research works printed but not linked: 3
- Vane, J. R., Proc. Fifth Intern. Congr. Pharmacol. (Karger, Basle, in the press).
- Milton, A. S., and Wendlandt, S., J. Physiol., 207, 76P (1970).
- Feldberg, W., Gupta, K. P., Milton, A. S., and Wendlandt, S., Brit. J. Pharmacol. (in the press).
Cited by
Items 401–500 of 781
Danon, A., Leibson, V., & Assouline, G. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb04336.x · Cited by 21
Ayoub, S. S., Pryce, G., Seed, M. P., Bolton, C., Flower, R. J., & Baker, D. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038638 · Cited by 20
Self-citationMultimodal Analgesia in the Aesthetic Plastic Surgery: Concepts and Strategies
Schoenbrunner, A. R., Joshi, G. P., & Janis, J. E. (2022) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000004310 · Cited by 21
Does amantadine induce acute psychosis? A case report and literature review
Xu, W., Ning, W., Xu, Y., & Hu, S. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s101569 · Cited by 20
del Castillo, J. R. E., Laroute, V., Pommier, P., Zemirline, C., Keïta, A., Concordet, D., & Toutain, P. (2006) · Journal of Animal Science · doi:10.2527/jas.2005-561 · Cited by 20
COX-3: Uncertainties and controversies
Kam, P. C. A., & So, A. (2008) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2008.11.003 · Cited by 26
Barnard, S., Storr, R. C., O’Neill, P., & Park, B. K. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb07099.x · Cited by 20
Ayoub, S. S., & Flower, R. J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172609 · Cited by 19
Self-citationFrom Low-Grade Inflammation in Osteoarthritis to Neuropsychiatric Sequelae: A Narrative Review
Naumovs, V., Groma, V., & Mednieks, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416031 · Cited by 21
“The prostaglandin E (PGE) family was described together with antipyretic drugs, such as acetylsalicylic acid [68,69].”
BackgroundMonda, M., Amaro, S., Sullo, A., & Luca, B. D. (1996) · Prostaglandins · doi:10.1016/0090-6980(96)00001-9 · Cited by 19
Areas of Emerging Interest in Analgesia: Cardiovascular Complications
Hillis, W. S. (2002) · American Journal of Therapeutics · doi:10.1097/00045391-200205000-00011 · Cited by 23
Doherty, N. S., Beaver, T. H., Chan, K. Y., Dinerstein, R. J., & Diekema, K. A. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14173.x · Cited by 19
Biological Properties of Cyclooxygenase Products
Vane, J. R., & Botting, R. M. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-198875-3.50009-8 · Cited by 24
Self-citationMechanism of action, potency and efficacy: considerations for cell therapies
Simon, C. G., Bozenhardt, E. H., Celluzzi, C. M., Dobnik, D., Grant, M., Lakshmipathy, U., Nebel, T., Peltier, L., Ratcliffe, A., Sherley, J. L., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05179-7 · Cited by 24
“There is evidence that acetaminophen inhibits prostaglandin synthesis [54], inhibits COX-3 [48], activates a vanilloid receptor (TRPV1) [55] and modulates the cannabinoid system [56].”
BackgroundInhibition of prostaglandin synthesis in intact cells by paracetamol (acetaminophen)
Graham, G. G., Robins, S.-A., Bryant, K. J., & Scott, K. F. (2001) · Inflammopharmacology · doi:10.1163/156856001300248407 · Cited by 22
“This problem applies to a widely cited study in which it was reported that paracetamol inhibited the production of PGE2 by the microsomal fraction of rabbit brain to a greater extent than the same fraction from dog spleen (Flower and Vane, 1972).”
Suwa, T., Urano, H., Kohno, Y., Suzuki, A., & Amano, T. (1987) · Inflammation Research · doi:10.1007/bf01974937 · Cited by 18
Amabeoku, G. J., Green, I., Eagles, P. F. K., & Benjeddou, M. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80038-0 · Cited by 18
SCHIZOPHRENIA AND NEUROACTIVE PEPTIDES FROM FOOD
Dohan, F. C. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92780-6 · Cited by 18
Indomethacin Reduces the Side Effects of Intrathecal Interferon
Mora, J. S., Kao, K., & Munsat, T. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401123100219 · Cited by 18
Parkhouse, J. (1975) · Drugs · doi:10.2165/00003495-197510050-00007 · Cited by 18
The use of opioids in the treatment of osteoarthritis: When, why, and how?
Goodwin, J. L. R., Kraemer, J. J., & Bajwa, Z. H. (2005) · Current Pain and Headache Reports · doi:10.1007/s11916-005-0018-3 · Cited by 18
“There are at least two proposed mechanisms of action for acetaminophen; it either inhibits cyclooxygenase-1 (COX-1) in the brain (as against COX-1 in peripheral tissues) [ 13 ] or it may inhibit COX-3, an enzyme found predominantly in the brain itself [14].”
BackgroundSirén, A. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90263-6 · Cited by 18
Hierton, C. (1981) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1981.tb00915.x · Cited by 18
Is prostaglandin fever mediated by the presynaptic release of hypothalamic 5-HT or norepinephrine?
Myers, R. D., & Waller, M. B. (1976) · Brain Research Bulletin · doi:10.1016/0361-9230(76)90048-4 · Cited by 18
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
Wiffen, P. J., Knaggs, R., Derry, S., Cole, P., Phillips, T., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012227 · Cited by 18
Searle, S. L., Muse, D. D., Paluch, E., Leyva, R., DePadova, E., Cruz‐Rivera, M., & Kellstein, D. E. (2020) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000828 · Cited by 17
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 19
Park, J. M., Han, Y. M., Jeong, M., Kim, E. H., Ko, W. J., Cho, J. Y., & Hahm, K. B. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-1034-z · Cited by 17
“The molecular basis of both the therapeutic benefit of and the pathogenesis caused by NSAIDs has been attributed to the ability of these drugs to inhibit COX, the rate-limiting enzyme in the biosynthesis of a family of prostaglandins, which plays a central role in the mediation of inflammatory, nociceptive, and cytopr…”
BackgroundHampel, M., Blasco, J., Babbucci, M., Ferraresso, S., Bargelloni, L., & Milan, M. (2017) · Marine Environmental Research · doi:10.1016/j.marenvres.2017.04.012 · Cited by 18
SUB-ACUTE TOXICITY STUDIES OF PARACETAMOL INFUSION IN ALBINO WISTAR RATS
Payasi, A., Chaudhary, M., Singh, B. M., Gupta, A., & Sehgal, R. (2010) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2010.020212 · Cited by 17
Salichs, M., Sabaté, D., Maté, O. C., & Homedes, J. M. (2011) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2011.01314.x · Cited by 17
Mancini, F., Landolfi, C., Muzio, M., Aquilini, L., Soldo, L., Coletta, I., Guglielmotti, A., Mantovani, A., Pinza, M., & Milanese, C. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.074 · Cited by 19
Conti, P., Bartle, L. M., Barbacane, R. C., Reale, M., & Sipe, J. D. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928938 · Cited by 17
Landis, C. A., Robinson, C. R., Helms, C. A., & Levine, J. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90709-9 · Cited by 17
Moyon, N. S., Singh, T. S., & Mitra, S. (2008) · Biophysical Chemistry · doi:10.1016/j.bpc.2008.09.004 · Cited by 17
AD-1590, a potent antagonist of lipopolysaccharide-induced fever in rabbits
Nakamura, H., Yokoyama, Y., Seto, Y., Kadokawa, T., & Shimizu, M. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb06935.x · Cited by 17
Lukáts, B., Egyed, R., Lénárd, L., & Karádi, Z. (2005) · Appetite · doi:10.1016/j.appet.2005.03.014 · Cited by 17
Direct spinal effect of intrathecal acetaminophen on visceral noxious stimulation in rabbits
Jensen, F. M., Dahl, J. B., & Frigast, C. (1992) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1992.tb03574.x · Cited by 17
Role of Neurohypophysial Hormones in Temperature Regulationa
Pittman, Q. J., Poulin, P., & Wilkinson, M. F. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55561.x · Cited by 17
Blocking of dog thyroid secretion in vitro by inhibitors of prostaglandin synthesis
Boeynaems, J. M., Sande, J. V., & Dumont, J. E. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90348-2 · Cited by 17
van Miert, A. S. J. P. A. M., & van Duin, C. T. M. (1979) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.1979.tb00355.x · Cited by 17
Moore, R. A., Derry, S., Aldington, D. J., & Wiffen, P. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011407 · Cited by 16
Starke, K. (1973) · Elsevier eBooks · doi:10.1016/b978-0-08-017922-3.50102-7 · Cited by 17
Garrone, B., Durando, L., Prenderville, J. A., Sokolowska, E., Milanese, C., Giorgio, F. P. D., Callaghan, C. K., & Bianchi, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-89629-y · Cited by 16
The Nitric Oxide-Mediated Regulation of Prostaglandin Signaling in Medicine
Kim, S. F. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800254-4.00009-x · Cited by 20
Cyclooxygenase-1 and -2 Play Contrasting Roles in Listeria-Stimulated Immunity
Theisen, E., McDougal, C. E., Nakanishi, M., Stevenson, D. M., Amador‐Noguez, D., Rosenberg, D. W., Knoll, L. J., & Sauer, J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700701 · Cited by 15
“is specific to CNS COX activity, whereas it lacks an effect against peripheral COX activity (78).”
BackgroundHoshijima, H., Hunt, M. A., Nagasaka, H., & Yaksh, T. L. (2021) · Journal of Pain Research · doi:10.2147/jpr.s308028 · Cited by 20
Walker, B. J., Polaner, D. M., & Berde, C. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-42974-0.00044-6 · Cited by 22
Traitement analgésique/antipyrétique: ibuprofène ou paracétamol? Mise au point
Olivé, G. (2006) · Therapies · doi:10.2515/therapie:2006034 · Cited by 17
Studies on the mechanism of action of anti-inflammatory drugs
Flower, R. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00410-9 · Cited by 16
Self-citationInhibition of prostaglandin biosynthesis by human low-density and high-density lipoproteins
Saeed, S. A., & Mitchell, M. D. (1982) · Prostaglandins Leukotrienes and Medicine · doi:10.1016/0262-1746(82)90041-5 · Cited by 16
Panneflek, T. J. R., Kuypers, K. L. A. M., Polglase, G. R., Derleth, D. P., Dekker, J., Hooper, S. B., van den Akker, T., & Pas, A. B. T. (2024) · European Journal of Pediatrics · doi:10.1007/s00431-024-05508-4 · Cited by 15
“Paracetamol, an acetanilide derivative, also decreases central PGE 2 concentrations [54, 55].”
BackgroundJeon, Y., Baek, S.-U., Park, S.-S., Kim, S., Baek, W.-Y., & Yeo, J. (2010) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2010.59.1.13 · Cited by 15
Pain Management - Practices, Novel Therapies and Bioactives
Waisundara, V. Y., Banjari, I., & Balkić, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87267 · Cited by 17
Bashir, S., & Morgan, W. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121194 · Cited by 15
Schachtel, B. P., Voelker, M., Sanner, K. M., Gagney, D., Bey, M., Schachtel, E., & Becka, M. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009360978 · Cited by 15
Ahmad, S., Rehman, T., & Abbasi, W. M. (2017) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.05.007 · Cited by 15
Fever: Links with an ancient receptor
Dinarello, C. A., Gatti, S., & Bartfai, T. (1999) · Current Biology · doi:10.1016/s0960-9822(02)00013-1 · Cited by 15
Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.
Ae, F., & Rosenberg, F. J. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb01809.x · Cited by 15
Histaminemia after aspirin challenge in aspirin-sensitive asthmatics
Szmidt, M., Grzelewska-Rzymowska, I., Rozniecki, J., Kowalski, M. L., & Rychlicka, I. (1981) · Inflammation Research · doi:10.1007/bf01991472 · Cited by 15
Platelet Aggregation Mechanisms and Their Implications in Haemostasis and Inflammatory Disease
Willis, A. L. (1978) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-66888-3_6 · Cited by 15
Wallenstein, M. C., & Bito, L. Z. (1977) · Neuropharmacology · doi:10.1016/0028-3908(77)90121-6 · Cited by 15
Rose, A. J., & Collins, A. J. (1974) · Prostaglandins · doi:10.1016/s0090-6980(74)80092-4 · Cited by 15
Nogueira, A. F., & Nunes, B. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-12046-7 · Cited by 14
Paracetamol and opioid pathways: a pilot randomized clinical trial
Pickering, G. P., Moustafa, F., Desbrandes, S., Cardot, J.-M., Roux, D., & Dubray, C. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01010.x · Cited by 16
Choudhuri, A. H., & Uppal, R. (2011) · Anesthesia Essays and Researches · doi:10.4103/0259-1162.94777 · Cited by 14
Kein�nen, S., Simil�, S., & Kouvalainen, K. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00644604 · Cited by 14
“Acetylsalicylic acid, indomethacin and paracetamol have an inhibitory effect on brain PG-synthetase and this effect correlates well with their antipyretic potency in vivo [ 14 ].”
BackgroundPain Management After Thoracic Surgery
Pennefather, S. H., & McKevith, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0184-2_46 · Cited by 22
Cyclooxygenase Isoform Exchange Blocks Brain-Mediated Inflammatory Symptoms
Wilhelms, D., Mirrasekhian, E., Zajdel, J., Singh, A. K., & Engblom, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166153 · Cited by 17
Effect of Niprisan® on single oral dose pharmacokinetics of paracetamol in rats
Adzu, B., Garba, M., Haruna, A., Maman, M., Wambebe, C. O., & Gamaniel, K. (2001) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190397 · Cited by 14
BLACK, A. K., Greaves, M. W., & Hobby, C. N. (1980) · Prostaglandins and Medicine · doi:10.1016/0161-4630(80)90112-3 · Cited by 14
Anti-Inflammatory Agents: Nonsteroidal Anti-Inflammatory Drugs
Masuda, K. (1984) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69222-2_12 · Cited by 14
Baumann, J., von Bruchhausen, F., & Wurm, G. (1983) · Prostaglandins Leukotrienes and Medicine · doi:10.1016/0262-1746(82)90087-7 · Cited by 14
Central Effects of Zomepirac on Pain Evoked by Intraneural Stimulation in Man
Schady, W., & Torebjörk, H. E. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb01815.x · Cited by 14
Central cardiovascular and thermal effects of prostacyclin in rats
Sirén, A. (1981) · Prostaglandins · doi:10.1016/0090-6980(81)90023-x · Cited by 14
Prostaglandin E 2 Production by Brain Endothelial Cells and the Generation of Fever
Blomqvist, A. G. (2023) · DNA and Cell Biology · doi:10.1089/dna.2022.0662 · Cited by 13
Eskilsson, A., Shionoya, K., Engblom, D., & Blomqvist, A. G. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0313-21.2021 · Cited by 17
“Prostaglandins (PGs) have been known as the critical mediator of fever since the 1970s, when their production by cyclooxygenase (Cox) enzymes was shown to be the target of antipyretic and anti-inflammatory drugs (Vane, 1971; Flower et al., 1972; Flower and Vane, 1972).”
Yue, Y., Collaku, A., Brown, J. D., Buchanan, W. L., Reed, K. L., Cooper, S. A., & Otto, J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.07.422 · Cited by 13
Antipyretic therapy: clinical pharmacology
Lee, J. J., & Simmons, D. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00054-9 · Cited by 17
Shorr, R. I., Kao, K.-J., Pizzo, S. V., Rauckman, E. J., & Rosen, G. M. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90005-2 · Cited by 13
THE USE OF ANALGESICS IN THE MANAGEMENT OF PAIN IN RHEUMATIC DISEASES
Moreland, L. W., & Clair, E. W. S. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70059-4 · Cited by 14
Nonsteroidal Antiinflammatory and Antiarthritic Drugs
Gund, P., & Jensen, N. P. (1983) · Medicinal chemistry · doi:10.1016/b978-0-12-695150-9.50011-8 · Cited by 13
Examination of mouse and rat tissues for evidence of dual forms of the fatty acid cyclooxygenase
Lysz, T. W., Zweig, A., & Keeting, P. E. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90182-7 · Cited by 13
Screening for Inhibitors of Prostaglandin and Thromboxane Biosynthesis
Gryglewski, R. J. (1977) · Springer eBooks · doi:10.1007/978-1-4684-2778-3_8 · Cited by 13
Förström, M. D. L., Goldyne, M. E., & WINKELMANN, R. K. (1974) · Prostaglandins · doi:10.1016/0090-6980(74)90073-2 · Cited by 13
Paracetamol for acute treatment of episodic tension-type headache in adults
Stephens, G., Derry, S., & Moore, R. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011889 · Cited by 13
Shao, X., Wang, Y., Gong, Z.-F., Li, Y., Tan, D.-Q., Lin, J.-G., Pei, W., & Wang, D. (2023) · Water Research · doi:10.1016/j.watres.2023.120783 · Cited by 12
Saglam, G., Gündüz, Ö., & Ulugöl, A. (2014) · Acta Neurologica Belgica · doi:10.1007/s13760-013-0272-9 · Cited by 12
Antipyretic effect of central α-MSH summates with that of acetaminophen or ibuprofen
Deeter, L. B., Martin, L. W., & Lipton, J. M. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90203-7 · Cited by 12
Fever and Its Role in Disease: Rationale for Antipyretics
Kasting, N. W., Veale, W. L., & Cooper, K. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68569-9_2 · Cited by 12
THE ANTIPYRETIC EFFECT OF TILORONE HYDROCHLORIDE IN THE CAT
Clark, W. G., & ROBINS, J. A. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb08457.x · Cited by 12
Lin, M. T. (1978) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00584454 · Cited by 12
“Introduction There is much evidence that antipyretics which have been shown to inhibit prostaglandin synthetase in in vitro systems ( Vane, 1971: Flower and Vane, 1972) have no effect on body temperature of afebrile animals and man (Cranston et aI.,1970: Clark and Cumby, 1975: Rosendorff and…”
BackgroundSuprofen: the Pharmacology and Clinical Efficacy of a New Non-narcotic Peripheral Analgesic
Tolman, E. L., Rosenthale, M. E., Capetola, R. J., & McGuire, J. L. (1984) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00507-5 · Cited by 12
Sensitivity of hypothalamic sites to salicylate and prostaglandin
Vaughn, L. K., Veale, W. L., & Cooper, K. E. (1979) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y79-018 · Cited by 12
Reflections on possible mechanisms of action of anti-inflammatory drugs
Rooney, P. J., Lee, P. J., Brookes, P., & Dick, W. C. (1973) · Current Medical Research and Opinion · doi:10.1185/03007997309111714 · Cited by 12
The hypothalamus and the pharmacology of thermoregulation
Milton, A. S. (1978) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-03506-9_5 · Cited by 12
Rosendorff, C., & Woolf, C. J. (1979) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-66891-3_10 · Cited by 12
Paracetamol: Update on its Analgesic Mechanism of Action
Mallet, C., Eschalier, A., & Daulhac, L. (2017) · Pain Relief - From Analgesics to Alternative Therapies · doi:10.5772/66649 · Cited by 11
SEO, Y., Kwon, M., CHOI, H., Choi, S. M., NAM, J., Lee, J., JUNG, J., PARK, S., & Suh, H. W. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.06.020 · Cited by 12
Ahmad, S., Rehman, T., & Abbasi, W. M. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60329-7 · Cited by 11
Metadata
- Authors
- FLOWER, R. J., & VANE, J. R.
- Affiliations
- Royal College of Surgeons of England (GB)
- Venue
- Nature
- Published
- 1972-12
- Volume
- 240
- Issue
- 5381
- Pages
- 410-411
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003880412
- Cited by
- 779
- References
- 20
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 13 · 2022: 13 · 2021: 15 · 2020: 13 · 2019: 13 · 2018: 12 · 2017: 15 · 2016: 11 · 2015: 22 · 2014: 10 · 2013: 17 · 2012: 18
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- paracetamol, 4-acetamidophenol, prostaglandin synthetase, cyclooxygenase inhibition, antipyretic activity, aspirin-like drugs, brain, analgesia, anti-inflammatory activity
- MeSH terms
- Acetaminophen, Animals, Aspirin, Brain, Dogs, Indomethacin, Ligases, Prostaglandins, Rabbits, Spleen, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.